IGF1 and hyperprolactinemia: The pathophysiology of gigantomastia is still unknow; although no precise mechanism is known for this rare clinical entity, theories such as end-organ hyper-sensitivity, autoimmune stimulation antibodies, high IGF-1 and hyperprolactinemia have been proposed.